Mike Hollan

LabConnect will utilize the consulting firm’s assets to improve its clinical trial services.

The new tests are reportedly more accurate at detecting early-stage pancreatic cancer.

Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion

The MagicTouch will be the focus of the Magical-ISR study.

Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.

While human infections of the virus are rare, a strain recently appeared in dairy cows before infecting a human in Texas.

Rahman discusses the new opportunities that digital twins present to researchers.

The council was established as part of NORD’s Project RDAC.

The Health Cube will increase remote and virtual care options for populations living in remote areas.

BrandShield states that it has identified sites selling counterfeit versions of Wegovy and Ozempic, among other drugs.

Butta discusses how new technologies are being implemented in at-home devices.

Tava’s network of therapists will be added to Health Advocate’s existing network.

Damien Bailly, president of established markets at Astellas, discusses why partnerships and collaborations are a critical organizational—and wider ecosystem—imperative in ensuring that patients have access to the medicines they need.

Users will be able to access DeepScribe’s documentation platform through AWS.

The program is designed to tackle issues related to the high cost of prescription medication.

This facility is the first of four facilities to be built in the area.

The meeting is scheduled for May in Switzerland.

The vaccine is already approved for older adults.

The move is part of Synaptogenix’s partnership with Cannasoul.

The pharmacy will now operate as Saveway Compounding Pharmacy, a Myonex company.

These expansions include a new product, along with improvements to existing products.

The move is intended to improve access to care at these critical sites.

FDA’s program will provide guidance to the development of the company’s Delphi-MD technology.

The technology will reportedly improve consumer engagement.

The vaccine can reportedly prevent infection from a fungal source that impacts both people and dogs.

The two programs will be offered to students and CVS interns.

Otsuka and Click Therapeutics co-developed Rejoyn, a digital therapeutic for MDD.

Erickson discusses his work developing unique, targeted autologous and allogeneic T cell therapeutics.

The two company’s will provide consumers with a platform where they can compare drug prices.

Mills is working in leadership in two roles, one of which puts her on the forefront of the genomic medicine movement.